Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Ye, Jian ^a   Yao, Yufeng ^a   Song, Qixue ^a   Li, Sisi ^a   Hu, Zhenkun ^a   Yu, Yubing ^a   Hu, Changqing ^a   Da, Xingwen ^a   Li, Hui ^a   Chen, Qiuyun ^a   Wang, Qing K ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MICRORNA; MIRN95 MICRORNA, HUMAN; RNA;

ANIMAL; BIOSYNTHESIS; CANCER TRANSPLANTATION; CELL CYCLE; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; HEP-G2 CELL LINE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MOUSE; PATHOLOGY; XENOGRAFT;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL MOVEMENT; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HETEROGRAFTS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICRORNAS; NEOPLASM TRANSPLANTATION; RNA, NEOPLASM;

EID: 84990950523     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34034     Document Type: Article

References (42)

1. Song, P. et al. Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china. Liver cancer 2, 31-39 (2013).
2. Asia-Pacific Working Party on Prevention of Hepatocellular, C. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. Journal of gastroenterology and hepatology 25, 657-663 (2010).
3. Yuen, M. F., Hou, J. L., Chutaputti, A. & Asia Pacific Working Party on Prevention of Hepatocellular, C. Hepatocellular carcinoma in the Asia pacific region. Journal of gastroenterology and hepatology 24, 346-353 (2009).
4. Kansagara, D., Papak, J. & Jou, J. H. Screening for hepatocellular carcinoma in chronic liver disease. Ann Intern Med 162, 240 (2015).
5. El-Serag, H. B. & Rudolph, K. L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557-2576 (2007).
6. Abbas, T. & Dutta, A. p21 in cancer: intricate networks and multiple activities. Nature reviews. Cancer 9, 400-414 (2009).
7. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. & Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816 (1993).
8. Deng, C., Zhang, P., Harper, J. W., Elledge, S. J. & Leder, P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684 (1995).
9. Moldovan, G. L., Pfander, B. & Jentsch, S. PCNA, the maestro of the replication fork. Cell 129, 665-679 (2007).
10. Umar, A. et al. Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell 87, 65-73 (1996).
11. Mortusewicz, O., Schermelleh, L., Walter, J., Cardoso, M. C. & Leonhardt, H. Recruitment of DNA methyltransferase I to DNA repair sites. Proceedings of the National Academy of Sciences of the United States of America 102, 8905-8909 (2005).
12. Zirbes, T. K. et al. Prognostic impact of p21/waf1/cip1 in colorectal cancer. Int J Cancer 89, 14-18 (2000).
13. Anttila, M. A. et al. p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer. Br J Cancer 79, 1870-1878 (1999).
14. Komiya, T. et al. p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung. Clin Cancer Res 3, 1831-1835 (1997).
15. Li, Y., Dowbenko, D. & Lasky, L. A. AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. The Journal of biological chemistry 277, 11352-11361 (2002).
16. Hwang, C. Y. & Kwon, K.-S. p21Cip1 regulation by ERK2: A post-translational mechanism that relays a proliferation signal. Cell Cycle 8, 3625-3626 (2014).
17. Lee, J. Y., Yu, S. J., Park, Y. G., Kim, J. & Sohn, J. Glycogen synthase kinase 3beta phosphorylates p21WAF1/CIP1 for proteasomal degradation after UV irradiation. Molecular and cellular biology 27, 3187-3198 (2007).
18. Rossig, L., Badorff, C., Holzmann, Y., Zeiher, A. M. & Dimmeler, S. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation. The Journal of biological chemistry 277, 9684-9689 (2002).
19. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
20. Iorio, M. V. & Croce, C. M. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO molecular medicine 4, 143-159 (2012).
21. Ram, P. & Santosh, K. K. Down-regulation of miRNA-106b inhibits growth of melanoma cells by promoting G1-phase cell cycle arrest and reactivation of p21/WAF1/Cip1 protein. Oncotarget 5, 10636-10649 (2014).
22. Hayashita, Y. et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer research 65, 9628-9632 (2005).
23. Fan, B. et al. Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2. Int J Oncol 47, 1025-1033 (2015).
24. Huang, X. et al. MiRNA-95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1. Cancer research 73, 6972-6986 (2013).
25. Huang, Z. et al. MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma. Cancer research 71, 2582-2589 (2011).
26. Hwang, S. J. et al. Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1. Oncotarget 6, 20434-20448 (2015).
27. Jun, K. H. et al. The rationality of N3 classification in the 7th edition of the International Union Against Cancer TNM staging system for gastric adenocarcinomas: a case-control study. International journal of surgery 12, 893-896 (2014).
28. Tian, X. L. et al. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature Protocols 427, 640-645 (2004).
29. Chen, S. et al. Genomic variant in CAV1 increases susceptibility to coronary artery disease and myocardial infarction. Atherosclerosis 246, 148-156 (2016).
30. Lu, Q. et al. Angiogenic factor AGGF1 promotes therapeutic angiogenesis in a mouse limb ischemia model. PLoS One 7, e46998 (2012).
31. Xu, Y. et al. Role of microRNA-27a in down-regulation of angiogenic factor AGGF1 under hypoxia associated with high-grade bladder urothelial carcinoma. Biochimica et biophysica acta 1842, 712-725 (2014).
32. Huang, Y. et al. Molecular Basis of Gene-Gene Interaction: Cyclic Cross-Regulation of Gene Expression and Post-GWAS Gene-Gene Interaction Involved in Atrial Fibrillation. PLoS genetics 11, e1005393 (2015).
33. Zhou, B. et al. MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth. Cancer Lett 333, 159-169 (2013).
34. Fan, C. et al. Novel roles of GATA1 in regulation of angiogenic factor AGGF1 and endothelial cell function. The Journal of biological chemistry 284, 23331-23343 (2009).
35. Chen, C. et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic acids research 33, e179 (2005).
36. Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nature Protocols 3, 1101-1108 (2008).
37. Zhao, Y. et al. Post-transcriptional regulation of cardiac sodium channel gene SCN5A expression and function by miR-192-5p. Biochimica et biophysica acta 1852, 2024-2034 (2015).
38. Zhou, J. et al. Cardiac sodium channel regulator MOG1 regulates cardiac morphogenesis and rhythm. Scientific reports 6, 21538 (2016).
39. Feng, S. et al. MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic acids research 39, 6669-6678 (2011).
40. Huang, B. et al. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 112, 1269-1279 (2008).
41. Kyzas, P. A., Stefanou, D., Batistatou, A. & Agnantis, N. J. Hypoxia-induced tumor angiogenic pathway in head and neck cancer: an in vivo study. Cancer letters 225, 297-304 (2005).
42. Xu, F. Y. et al. The antitumor activity study of ginsenosides and metabolites in lung cancer cell. American journal of translational research 8, 1708-1718 (2016